Conference Call and Webcast Access
AMAG Pharmaceuticals, Inc. will host a conference call and webcast today at 4:30 p.m. ET. To access the conference call via telephone, dial 1-877-412-6083 from the United States or 1-702-495-1202 for international access. A telephone replay of the conference call will be available from approximately 7:30 p.m. ET on May 9, 2012 until midnight on May 14, 2012. To access the replay, dial 1-855-859-2056 from the United States or 1-404-537-3406 for international access. The pass code for the live call and the replay is 79714574.
A live webcast of the conference call will be accessible through the Investors section of the company’s website at www.amagpharma.com beginning at 4:30 p.m. ET. Following the conference call, the webcast replay will be available at approximately 7:30 p.m. ET and will be archived on the AMAG Pharmaceuticals, Inc. website until midnight on June 9, 2012.
Inducement Equity AwardsIn connection with Mr. Heiden’s entry into his employment agreement, effective on the first day of Mr. Heiden’s employment, Mr. Heiden will be granted (i) an option to purchase 300,000 shares of common stock and (ii) 100,000 restricted stock units. The option will have an exercise price equal to the closing price of AMAG’s common stock on the grant date and will be exercisable in four equal annual installments beginning on the first anniversary of the grant date. The option will have a ten year term and be subject to the terms and conditions of the stock option agreement pursuant to which the option will be granted. The restricted stock units will vest in four equal annual installments beginning on the first anniversary of the grant date and will be subject to the restricted stock unit agreement pursuant to which the restricted stock units will be granted. These equity awards will be granted without stockholder approval as inducements material to Mr. Heiden’s entering into employment with AMAG in accordance with NASDAQ Listing Rule 5635(c)(4).
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts